Sold out68.77 KWD
Decapeptyl CR Injection 3.75 mg contains triptorelin, a long-acting gonadotropin-releasing hormone (GnRH) agonist. It is formulated as a controlled-release injection used in the management of hormone-dependent conditions, including prostate cancer, endometriosis, uterine fibroids, and certain fertility treatments.
For intramuscular injection only. Administered by a healthcare professional according to the prescribed treatment schedule, usually once every four weeks. Dosage and duration depend on the medical indication.
Triptorelin is clinically established in the management of hormone-sensitive conditions by reducing gonadotropin secretion and lowering sex hormone levels. The controlled-release formulation provides sustained therapeutic effect with monthly administration.
Active ingredient: triptorelin acetate 3.75 mg. Contains biodegradable polymer microspheres and pharmaceutical excipients designed for controlled-release intramuscular injection.
Provides sustained hormonal suppression, supports management of hormone-dependent conditions, offers convenient once-monthly dosing, and ensures controlled and consistent therapeutic effect.
France